Quick Answer
LEXICON PHARMACEUTICALS, INC. reported Total Assets of $184.99 million for the year ending 2025.
- LEXICON PHARMACEUTICALS, INC. showed a decrease of -38.0% in Total Assets from 2024 to 2025.
- This data is from LEXICON PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: $315.92 million | Q3 2011: $294.71 million | Q1 2012: $402.79 million | Q2 2012: $381.06 million | Q3 2012: $357.84 million | Q1 2013: $347.28 million | Q2 2013: $323.39 million | Q3 2013: $299.46 million | Q1 2014: $243.60 million | Q2 2014: $224.06 million | Q3 2014: $187.52 million | Q1 2015: $444.68 million | Q2 2015: $415.96 million | Q3 2015: $391.14 million | Q1 2016: $611.34 million | Q2 2016: $558.13 million | Q3 2016: $516.95 million | Q1 2017: $396.26 million | Q2 2017: $363.51 million | Q3 2017: $329.49 million | Q1 2018: $386.81 million | Q2 2018: $332.94 million | Q3 2018: $310.19 million | Q1 2019: $258.52 million | Q2 2019: $233.14 million | Q3 2019: $444.59 million | Q1 2020: $370.57 million | Q2 2020: $322.54 million | Q3 2020: $178.93 million | Q1 2021: $193.26 million | Q2 2021: $171.67 million | Q3 2021: $172.33 million | Q1 2022: $136.18 million | Q2 2022: $112.33 million | Q3 2022: $191.69 million | Q1 2023: $162.72 million | Q2 2023: $316.72 million | Q3 2023: $276.48 million | Q1 2024: $417.22 million | Q2 2024: $373.36 million | Q3 2024: $321.12 million | Q1 2025: $297.67 million | Q2 2025: $225.58 million | Q3 2025: $205.93 million.
- Over the full 16 years of available data (2010 to 2025), LEXICON PHARMACEUTICALS, INC.'s Total Assets has declined by 49.6%.
- Historical annual values: Fiscal year 2025: $184.99 million | Fiscal year 2024: $298.42 million | Fiscal year 2023: $229.43 million | Fiscal year 2022: $194.30 million | Fiscal year 2021: $136.91 million | Fiscal year 2020: $203.79 million | Fiscal year 2019: $417.72 million | Fiscal year 2018: $284.14 million | Fiscal year 2017: $436.54 million | Fiscal year 2016: $475.63 million | Fiscal year 2015: $651.96 million | Fiscal year 2014: $471.38 million | Fiscal year 2013: $274.16 million | Fiscal year 2012: $371.78 million | Fiscal year 2011: $430.51 million | Fiscal year 2010: $366.88 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: